SHR-1906
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
Guangdong Hengrui Pharmaceutical Co., Ltd
Overview
SHR-1906 is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
SHR-1906 clinical trials
Explore related
Medical disclaimer. This page summarizes research about SHR-1906 for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.